NeuroSoV is a biotech company focused on the discovery and development of cutting-edge therapies targeted at slowing down neurological disorders. Our first asset targets Parkinson Disease (PD), aiming to deliver the most effective and safe therapeutic solutions to slow-down and treat PD patients, ultimately improving their quality of life.
Our team is fuelled by the passion to make a difference for patients living with Neurologic/Neurodegenerative Diseases and is comprised of renowned scientists & international experts in the field of Neurosciences, Chemistry, Physics Pharmacology, Medicine and Executives in Business & Economics.
More informations & services quotes
We look forward to seeing you!
NeuroSoV is committed to operate in an open innovation framework with the highest degree of ethical and integrity practices. Our compromise is to deliver results under all applicable Standard Operating Procedures to comply with the best practices:
- In the domains of applicable laws and regulations worldwide;
- Assuring business practices and ethical behaviours at all levels;
- Following the demands of globalization in a competitive, ethical, sustainable and innovative way, embracing good citizenship values.
Our team is fuelled by the passion to make a difference for patients living with Neurologic/Neurodegenerative Diseases and is comprised of renowned scientists & international experts in the field of Neurosciences, Chemistry, Physics Pharmacology, Medicine and Executives in Business & Economics. NeuroSoV successfully established key strategic partnerships/alliances and active collaborations with both National and International Research Centres and Institutes that position us closer to achieving our objective for patients every single day.
